Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DA Davidson analyst Gil Luria raised his price target on MU to $3,000 from $2,100. That is a 43% uplift in one move. Luria kept his Buy rating. Micron's market cap sits near $1.18 trillion. Short interest is just 2.4% of free float, leaving little pressure on the downside from bears.
MRVL drew multiple changes simultaneously. Cantor Fitzgerald's C.J. Muse lifted his target to $350 from $330. The consensus target jumped to $322 from $309. Marvell carries a $252 billion market cap and remains a core AI networking bet.
PLTR also saw its consensus target tick up to $199.84 from $195.57. The analyst community is still warming to the data analytics company. Short interest is only 2.7% of free float.
Barclays made two medical device calls. The bank initiated ABT at Buy with a $120 target. It started at Sell with a $20 target. The divergence points to a split view on the healthcare equipment space.
Japan's foreign machine tool orders rose 66% year-on-year in August, according to ORTEX Alt Data. That spending backdrop supports the bullish case for semiconductor equipment and component suppliers. Marvell and Micron sit directly in that demand chain.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
